JB Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
JB Capital's ELV Position: Q1 2026 in Review
JB Capital increased its Elevance Health (ELV) stake by 3.9% in Q1 2026, buying an estimated $151K and bringing the position to 12,310 shares worth $3.6M. The position accounts for 0.15% of the portfolio, ranked #85.
JB Capital first reported a position in ELV in Q3 2021 and has held it in 19 quarters since. The position peaked at $4.21M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- JB Capital held 12,310 shares of Elevance Health worth $3.6M as of Q1 2026.
- JB Capital bought 460 Elevance Health shares in Q1 2026, an estimated $151K.
- Elevance Health made up 0.15% of JB Capital's portfolio in Q1 2026, its #85 holding.
- JB Capital first reported a position in Elevance Health in Q3 2021 and has held it in 19 quarters since.
- JB Capital's Elevance Health position peaked at $4.21M in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on JB Capital's 13F filing for Q1 2026, filed 27 Apr 2026.